In EMPD, genetic alterations include mutations in the phosphoinositide 3-kinase-AKT-mammalian target of rapamycin (PI3K-AKT-mTOR) signaling pathway [14] and mismatch repair genes, with evidence of microsatellite instability [15]. This evidence concerns the gene AKT1 and extramammary Paget disease.